Sewha Kim1, Yon Hee Kim2, Kyu Hun Choi3, Hyeon Joo Jeong4. 1. Department of Pathology, Ewha Womans University School of Medicine, Seoul, Korea. 2. Department of Pathology, Ajou University School of Medicine, Suwon, Korea. 3. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. 4. Department of Pathology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea. jeong10@yuhs.ac.
Abstract
BACKGROUND: CD44 is a marker of activated parietal epithelial cells (PECs), and is expressed in glomerular visceral epithelial cells (VECs) during development of segmental sclerosis. We explored the significance of glomerular epithelial CD44 expression in relation to segmental sclerosis in patients with mild IgA nephropathy (IgAN). METHODS: A total of 126 cases of IgAN were divided into three groups based on glomerular morphology: normal (group A, n = 30), mild mesangial proliferation without segmental sclerosis or synechia (SS) (group B, n = 31), or mild mesangial proliferation with SS (group C, n = 65). The number of CD44-expressing PECs and VECs was counted in each glomerulus and expressed as the mean number per case. RESULTS: CD44 staining was positive in VECs in 59.5 %, in PECs in 79.4 % and in both cell types in 56.3 % of cases. The number of CD44+ PECs or VECs was significantly higher in group C than in groups A or B. Cases with >1 CD44+ cell (PECs and VECs) per glomerulus were associated with increased urine protein/creatinine ratio (UPCr) at last follow-up. The presence of >1 CD44+ VEC/glomerulus was associated with increased UPCr and serum creatinine levels, and decreased estimated glomerular filtration rate (eGFR) even in the absence of SS at the time of biopsy. CONCLUSION: CD44 was expressed in PECs and VECs in association with SS in IgAN. Increased CD44 expression in VECs is a sign of active glomerular injury and dysfunction in these patients.
BACKGROUND:CD44 is a marker of activated parietal epithelial cells (PECs), and is expressed in glomerular visceral epithelial cells (VECs) during development of segmental sclerosis. We explored the significance of glomerular epithelial CD44 expression in relation to segmental sclerosis in patients with mild IgA nephropathy (IgAN). METHODS: A total of 126 cases of IgAN were divided into three groups based on glomerular morphology: normal (group A, n = 30), mild mesangial proliferation without segmental sclerosis or synechia (SS) (group B, n = 31), or mild mesangial proliferation with SS (group C, n = 65). The number of CD44-expressing PECs and VECs was counted in each glomerulus and expressed as the mean number per case. RESULTS:CD44 staining was positive in VECs in 59.5 %, in PECs in 79.4 % and in both cell types in 56.3 % of cases. The number of CD44+ PECs or VECs was significantly higher in group C than in groups A or B. Cases with >1 CD44+ cell (PECs and VECs) per glomerulus were associated with increased urine protein/creatinine ratio (UPCr) at last follow-up. The presence of >1 CD44+ VEC/glomerulus was associated with increased UPCr and serum creatinine levels, and decreased estimated glomerular filtration rate (eGFR) even in the absence of SS at the time of biopsy. CONCLUSION:CD44 was expressed in PECs and VECs in association with SS in IgAN. Increased CD44 expression in VECs is a sign of active glomerular injury and dysfunction in these patients.
Entities:
Keywords:
CD44; IgA nephropathy; Parietal epithelial cell; Podocyte; Proteinuria
Authors: Bart Smeets; Christoph Kuppe; Eva-Maria Sicking; Astrid Fuss; Peggy Jirak; Toin H van Kuppevelt; Karlhans Endlich; Jack F M Wetzels; Hermann-Josef Gröne; Jürgen Floege; Marcus J Moeller Journal: J Am Soc Nephrol Date: 2011-06-30 Impact factor: 10.121
Authors: Sandrine Florquin; Raffaele Nunziata; Nike Claessen; Frank M van den Berg; Steven T Pals; Jan J Weening Journal: Am J Kidney Dis Date: 2002-02 Impact factor: 8.860
Authors: Khalil El Karoui; Gary S Hill; Alexandre Karras; Luc Moulonguet; Valérie Caudwell; Alexandre Loupy; Patrick Bruneval; Christian Jacquot; Dominique Nochy Journal: Kidney Int Date: 2010-12-22 Impact factor: 10.612
Authors: Jiong Zhang; Jeffrey W Pippin; Ronald D Krofft; Shokichi Naito; Zhi-Hong Liu; Stuart J Shankland Journal: Am J Physiol Renal Physiol Date: 2013-03-13
Authors: Leal C Herlitz; Andrew S Bomback; Michael B Stokes; Jai Radhakrishnan; Vivette D D'Agati; Glen S Markowitz Journal: Clin J Am Soc Nephrol Date: 2014-04-10 Impact factor: 8.237
Authors: Nazanin Kabgani; Tamara Grigoleit; Kevin Schulte; Antonio Sechi; Sibille Sauer-Lehnen; Carmen Tag; Peter Boor; Christoph Kuppe; Gregor Warsow; Sandra Schordan; Jörg Mostertz; Ravi Kumar Chilukoti; Georg Homuth; Nicole Endlich; Frank Tacke; Ralf Weiskirchen; Georg Fuellen; Karlhans Endlich; Jürgen Floege; Bart Smeets; Marcus J Moeller Journal: PLoS One Date: 2012-04-18 Impact factor: 3.240
Authors: Sebastian S Roeder; Taylor J Barnes; Jonathan S Lee; India Kato; Diana G Eng; Natalya V Kaverina; Maria W Sunseri; Christoph Daniel; Kerstin Amann; Jeffrey W Pippin; Stuart J Shankland Journal: Kidney Int Date: 2016-12-18 Impact factor: 10.612